top of page
Search Results

336 items found for "protease-activated receptors (PARs)"

  • Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    Receptors Andrew Dates Discriminating between the extracellular scaffolding and G protein signaling activation, suggesting that non-release or partial release of the TA is unlikely to activate the receptor the TA-mediated activation of aGPCRs. As an undergraduate, he studied opioid receptor trafficking and G protein conformational dynamics in We utilize several genetically modified mouse models to investigate requirements for receptor activator

  • Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target

    GPCRs in Oncology and Immunology Expression pattern and clinical significance of beta 2-adrenergic receptor indicator and future therapeutic target Published date November 1, 2022 Abstract Purpose: Beta 2-Adrenergic Receptor Percent positivity and relative density (mean ± SD) of protein were higher in the case group as compared Uma Shankar Singh, Rakesh Kumar Singh Tags GPCR; OSCC; Oral cancer; Prognostic factor; β2-Adrenergic Receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 107 with Dr. Roger Sunahara

    His main area of research focuses on the structural and pharmacological bases for hormone-mediated activation of G proteins by G protein-coupled receptors (GPCRs). for agonist-mediated activation of G proteins. We continue to utilize these data to better understand the basis for receptor-G protein specificity and Some of these changes are associated with G protein activation while the functional consequences of other

  • Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    of adhe-sion G-protein coupled receptors (ADGRs), as this extracellular domain contains an integral the receptor. However, several ADGRs can be activated without GPS cleavage. (CELSRs) are conserved adhesion G protein-coupled receptors; they are essential for embryogenesis and coupled receptors (aGPCR) are a family of 32 mammalian proteins with a defining conserved GPCR autoproteolysis

  • From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction

    Lysophosphatidic acid (LPA) is a lipid that activates G protein-coupled receptors (GPCRs), enhancing In these cells, the mitogenic activity of LPA is mediated by LPA Receptor 1 (LPAR1), a GPCR. Specifically, CCNs secreted into the extracellular space can facilitate the activation of additional receptors and signal transduction pathways, contributing to the biphasic delayed responses typically In this way, an extracellular signal (LPA or S1P) can activate GPCR-mediated intracellular signaling

  • Ep 47 with Dr Simone Promel Dr Ines Liebscher

    These extraordinary receptors, about which there was not much known other than that they are huge and With the little knowledge on these receptors available, there were multiple questions to tackle. Starting with proving and characterizing G-protein coupling, Ines spends several years studying the activation GPCR scientists around the globe she established a tethered agonist -extracellular matrix- mechano-activation - activation scenario that forms the basis for her current projects that focus on the structural and

  • Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Mthl10

    Immunology Drosophila cytokine GBP2 exerts immune responses and regulates GBP1 expression through GPCR receptor Moreover, the GBP2-induced response was silenced by pre-treatment with dsRNA targeting the GBP receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma

    Oncology and Immunology Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma Published date September 16, 2023 Abstract "Background Wei , Tianyi Zhang , Yu Zhu , Jia Feng , Feng Qin , Yanwen Yang , Chuanyuan Wei , Jianying Gu Tags G protein-coupled receptors , Immunotherapy , Melanoma , Multi-omics , Pan-cancer , Tumor microenvironment , scRNA-seq and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 142 with Dr Claudia Stäubert

    receptors (GPCRs) due to a stay as a scholarship student in the lab of Thue Schwartz (Copenhagen, Denmark Metabolite Activation of GPCRs: A Fascinating Discovery Claudia and Yamina discussed the role of metabolites in activating GPCRs, a process that they found fascinating. metabolites and their receptors, particularly in relation to fermented foods. activity.

  • Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses in sterile and infectious inflammation

    coupled receptor GPR101 mediates the phagocyte-directed pro-resolving activities of RvD5n-3 DPA (n-3 Herein, we investigated the endogenous role of this pro-resolving receptor in modulating macrophage biology macrophages obtained from naïve MacGpr101KO mice displayed a marked shift in the expression of phenotypic and activation markers, including the Interleukin (IL)-10 and IL-23 receptors. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 114 with Dr. Robert F. Bruns

    His doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors. postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

  • Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma

    Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma Date & Time Friday, November 3rd / Sakmar’s laboratory at Rockefeller University, where she studies the signaling and degradation of G protein-coupled receptors. Walsh Grant Fellowship to develop novel methods of synthesizing 2-imidazoline scaffolds to be used as proteasome

  • Dr. GPCR Summit 2021 Live Talks

    Eiger September 13, 2021 at 7:00:00 PM Learn More >> A distinct activation mechanism in GPCR dimers: 13, 2021 at 8:00:00 PM Learn More >> Heat Shock Protein 90 is a Novel Opioid Receptor Signaling Regulator Chris de Graaf September 14, 2021 at 12:00:00 PM Learn More >> Designer G protein-coupled receptors as Meriem Semache September 15, 2021 at 2:00:00 PM Learn More >> GPCR activation mechanisms across classes Ajay Yekkirala September 16, 2021 at 2:00:00 PM Learn More >> Chaperoning G protein-coupled receptors

  • Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq

    RNA-seq Published date August 8, 2023 Abstract "Background: About one-third of patients with estrogen receptor alpha (ERα)-positive breast cancer have tumors which are progesterone receptor (PR) negative. with G protein-coupled receptor (GPCR) pathways which have been described to support growth, invasiveness alpha , gene expression , Progesterone receptor. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 150 with Dr GPCR Team

    GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the She is also very active within the pharmacology community and currently serves on the editorial board molecular dynamics simulations and free energy landscape analysis to understand the signaling pathways and activation mechanisms of the Dopamine D3 receptor and the CXCR4-CXCL12 complex.

  • Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4

    < GPCR News < GPCRs in Oncology and Immunology Lactate receptor GPR81 drives breast cancer growth and properties and Notch ligand DLL4 Published date November 22, 2023 Abstract " Background: The lactate receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis

    coupled receptors (GPCRs) by eicosanoids and actin cytoskeleton reorganization remains largely unexplored Using a model of human adrenocortical cancer cells, here we established that activation of the GPCR OXER1 reduced by pertussis toxin (PTX) and GUE1654, a biased antagonist for the Gβγ pathway downstream of OXER1 activation either 5-oxo-ETE or LPA is partially dependent on the transactivation of the epidermal growth factor receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis

    receptors (GPCRs), the biggest family of signaling receptors, account for 34 % of all the drug targets Differential expression and functional enrichment analyses were performed; protein-protein interaction Results: A GPCR-related risk score containing eight GPCR-related genes (atypical chemokine receptor 3 receptor 8 (GRM8), hydroxycarboxylic acid receptor 1 (HCAR1), 5-hydroxytryptamine receptor 5A (HTR5A and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 32 with Dr. Chris Tate

    basis of GPCR pharmacology through structure determination of the β1-adrenoceptor and adenosine A2A receptor active state. Structures have been determined by X-ray crystallography of receptors coupled to either mini-Gs or mini-Go , and also by electron cryo-microscopy of receptors coupled to mini G protein bound to βγ subunits. a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D receptor

  • Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation

    reveals unexpected differences in downstream pathway activation Published date July 16, 2024 Abstract In the present study, we first develop a mechanistic mathematical model of a G-protein coupled receptor This led us to hypothesize that CYSLTR2 mutations in UM must co-occur with other mutations to activate for co-occurring mutations involving the plexin/semaphorin pathway, which has been shown capable of activating and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Emerging GPCR targets for AUD: Insights from preclinical studies

    Emerging GPCR targets for AUD: Insights from preclinical studies Published date July 5, 2024 Abstract "G protein-coupled receptors (GPCRs) are the largest group of membrane receptors in the central nervous system and one of the key proteins for signal transduction between cells. Currently, many drugs available on the market act via GPCRs and these receptors remain attractive targets and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity

    glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity Published date February 2, 2024 Abstract " Background: Interferon-γ-inducible protein of 10 kDa (IP- 10/CXCL10) is a dual-function CXC chemokine that coordinates chemotaxis of activated T cells and natural killer (NK) cells via interaction with its G protein-coupled receptor (GPCR), CXC chemokine receptor and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone

    receptors (GPCRs) mediate a wide spectrum of physiological functions, including the development, remodeling Fibrous dysplasia (FD) of the bone is characterized by fibrotic, expansile bone lesions caused by activating We previously showed that ColI(2.3)+/Rs1+ mice, in which Gs-GPCR signaling was hyper-activated in osteoblastic cell lineages using an engineered receptor strategy, developed a fibrotic bone phenotype with trabecularization coupled receptor signaling , GPCR , Gnas , Gsα .

  • Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca2+ Flux

    Finally, we identified that G protein-coupled receptor (GPCR)-phospholipase C (PLC)-inositol trisphosphate The chemokine interleukin-8 (CXCL8/IL-8) is indispensable for the activation and trafficking of inflammatory G protein-coupled receptor (GPCR)-phospholipase C (PLC)-inositol trisphosphate receptor (IP3R)-SOC signaling was activated by IL-8, releasing the intracellular Ca2+ stores from endoplasmic reticulum (ER). and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • GPR56 signaling pathway network and its dynamics in the mesenchymal transition of glioblastoma

    receptor 56 (GPR56/ADGRG1) is a multifunctional adhesion GPCR involved in diverse biological processes study along with detailed literature mining of the molecular events plausibly associated with GPR56 activity The map incorporates more than 100 molecular entities including kinases, receptors, ion channels, and We also considered intracellular and extracellular factors that may influence the activity of the pathway and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation

  • Ep 04 with Dr. Graciela Pineyro

    Graciela Pineyro’s love for GPCR pharmacology started in Uruguay where she first worked on the serotonin receptors Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling , trafficking, and their ability to activate different signaling pathways and signaling bias.

  • Ep 71 with Dr. Jean Martin Beaulieu

    for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric In addition to basic research, the Beaulieu group is also actively implicated in translational research

  • Ep 50 with Dr. Thomas P. Sakmar

    also went on to discover a “counterion switch” in visual pigments and to develop strategies to assay receptor-G-protein interactions and activation kinetics. from this work, such as the concept of “functional micro-domains” and the “helix movement model of receptor , the parallel development of bioorthogonal labeling strategies to couple fluorophores to expressed receptors The CysLTR2 oncoprotein displays biased constitutive activity – it activates Gq/11 but does not undergo

bottom of page